0001732374-18-000001.txt : 20180222 0001732374-18-000001.hdr.sgml : 20180222 20180222102021 ACCESSION NUMBER: 0001732374-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 EFFECTIVENESS DATE: 20180222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Unleash Immuno Oncolytics, Inc. CENTRAL INDEX KEY: 0001732374 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306188 FILM NUMBER: 18631329 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE, SUITE 304 CITY: ST. LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-730-0050 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE, SUITE 304 CITY: ST. LOUIS STATE: MO ZIP: 63108 D 1 primary_doc.xml X0708 D LIVE 0001732374 Unleash Immuno Oncolytics, Inc. 4320 FOREST PARK AVENUE, SUITE 304 ST. LOUIS MO MISSOURI 63108 314-730-0050 DELAWARE None None Corporation true 2015 Daniel Katzman c/o Unleash Immuno Oncolytics, Inc. 4320 Forest Park Avenue, Suite 304 St. Louis MO MISSOURI 63108 Executive Officer Director Bolten Charles c/o Unleash Immuno Oncolytics, Inc. 4320 Forest Park Avenue, Suite 304 St. Louis MO MISSOURI 63108 Director Ricardo Lisandro Bril c/o Unleash Immuno Oncolytics, Inc. 4320 Forest Park Avenue, Suite 304 St. Louis MO MISSOURI 63108 Director Ariel Muslera c/o Unleash Immuno Oncolytics, Inc. 4320 Forest Park Avenue, Suite 304 St. Louis MO MISSOURI 63108 Director Biotechnology Decline to Disclose 06b false 2018-02-16 false true false 0 3000000 3000000 0 false 1 0 0 0 false Unleash Immuno Oncolytics, Inc. /s/ Daniel Katzman Daniel Katzman CEO 2018-02-22